PAT 201 Practice Questions
COMPLETE QUESTIONS AND
ANSWERS | ALREADY PASSED |
2025 LATEST!!
Save
Terms in this set (63)
,Answer: b The nurse knows that governmental
Rationale: Health drug legislation requires the
Canada requires drug manufacturer to prove that a
that drug drug is both safe and
manufacturers a. Free of adverse effects and
demonstrate both potential reactions
the safety and the b. Effective for a specified purpose
effectiveness c. Reasonable in cost and easily
of accessible
pharmaceutical d. Beneficial to various population
products. groups
Options a, c, and
d are incorrect.
All
drugs have
potential
reactions and
adverse effects.
Many factors
determine the
cost of a drug
and newly
approved drugs
may be
the most
expensive and
not fully covered
,by healthcare
insurance
plans. Not all
drugs have been
tested in diverse
populations and
women, minority
ethnic groups,
children, and
older adults are
often
underrepresente
d in drug
research studies.
Cognitive Level:
Applying; Client
Need: Safe and
Effective Care
Environment;
Nursing Process:
Implementation
, Answer: b The drug research participant with a
Rationale: Phase particular disease is taking
2 of the clinical part in an investigative study to
investigation examine the effects of a new
relies on studying drug. Previously, this drug was tested
clients with the using healthy volunteers.
disease to be The next phase of the clinical trial
treated. Options investigation in which the
a, c, and d are client will be participating is
incorrect. Phase 1 a. Phase 1
studies use small b. Phase 2
groups of c. Phase 3
healthy subjects. d. Phase 4
Phase 3 studies
use large
numbers of
subjects
with the condition
being treated by
the drug. Phase 4
is
considered post-
marketing
surveillance after
the drug has
been
approved.
COMPLETE QUESTIONS AND
ANSWERS | ALREADY PASSED |
2025 LATEST!!
Save
Terms in this set (63)
,Answer: b The nurse knows that governmental
Rationale: Health drug legislation requires the
Canada requires drug manufacturer to prove that a
that drug drug is both safe and
manufacturers a. Free of adverse effects and
demonstrate both potential reactions
the safety and the b. Effective for a specified purpose
effectiveness c. Reasonable in cost and easily
of accessible
pharmaceutical d. Beneficial to various population
products. groups
Options a, c, and
d are incorrect.
All
drugs have
potential
reactions and
adverse effects.
Many factors
determine the
cost of a drug
and newly
approved drugs
may be
the most
expensive and
not fully covered
,by healthcare
insurance
plans. Not all
drugs have been
tested in diverse
populations and
women, minority
ethnic groups,
children, and
older adults are
often
underrepresente
d in drug
research studies.
Cognitive Level:
Applying; Client
Need: Safe and
Effective Care
Environment;
Nursing Process:
Implementation
, Answer: b The drug research participant with a
Rationale: Phase particular disease is taking
2 of the clinical part in an investigative study to
investigation examine the effects of a new
relies on studying drug. Previously, this drug was tested
clients with the using healthy volunteers.
disease to be The next phase of the clinical trial
treated. Options investigation in which the
a, c, and d are client will be participating is
incorrect. Phase 1 a. Phase 1
studies use small b. Phase 2
groups of c. Phase 3
healthy subjects. d. Phase 4
Phase 3 studies
use large
numbers of
subjects
with the condition
being treated by
the drug. Phase 4
is
considered post-
marketing
surveillance after
the drug has
been
approved.
